Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 18, 2020 - Issue 9
Submit an article Journal homepage
293
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Letter to the Editor - New Pharmacotherapy for Heart Failure with Reduced Ejection Fraction

Adam Ioannoua Department of Cardiology, Royal Free Hospital, Royal Free NHS Foundation Trust, London, UKORCID Iconhttps://orcid.org/0000-0001-5017-8657View further author information
ORCID Icon,
Sofia Metaxab Department of Cardiology, Wrexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UKView further author information
,
Steny Simonb Department of Cardiology, Wrexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UKView further author information
,
Amit K. J. Mandalb Department of Cardiology, Wrexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UKView further author information
&
Constantinos G. Missourisb Department of Cardiology, Wrexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK;c Medical School, University of Cyprus Medical School, Nicosia, CyprusCorrespondence[email protected]
View further author information
Pages 651-652 | Received 30 Mar 2020, Accepted 17 Jul 2020, Published online: 01 Aug 2020

References

  • Sotirakos S, Wheen P, Spiers J, et al. New pharmacotherapy for heart failure with reduced ejection fraction. Expert Rev Cardiovasc Ther. 2020 Jun 30;1–9. DOI:https://doi.org/10.1080/14779072.2020.1784007.
  • McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.
  • Desai AS, Solomon SD, Shah AM, et al. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial. JAMA. 2019;322:1077–1084.
  • Velazquez EJ, Morrow DA, DeVore AD, et al. Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med. 2019;380:539–548.
  • Ioannou A, Metaxa S, Simon S, et al. Comparison of the effect of sacubitril/valsartan on left ventricular systolic function in patients with non-ischaemic and ischaemic cardiomyopathy. Cardiovasc Drugs Ther. 2020 Jul 9;1–8. DOI:https://doi.org/10.1007/s10557-020-07036-3.
  • de Groote P, Delour P, Mouquet F, et al. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. Am Heart J. 2007;154:589–595.
  • Maurer MS, Sackner-Bernstein JD, El-Khoury Rumbarger L, et al. Mechanisms underlying improvements in ejection fraction with carvedilol in heart failure. Circ Heart Fail. 2009;2:189–196.
  • Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta‐blocker therapy. Circulation. 2003;108:1945–1953.
  • Park CS, Park JJ, Mebazaa A, et al. Characteristics, outcomes, and treatment of heart failure with improved ejection fraction. J Am Heart Assoc. 2019;8:e011077.
  • Lee YJ, Jeong SY, Karbowski M, et al. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell. 2004;15:5001–5011.
  • Marín-García J, Akhmedov AT, Moe GW. Mitochondria in heart failure: the emerging role of mitochondrial dynamics. Heart Fail Rev. 2013;18:439–456.
  • Xia Y, Chen Z, Chen A, et al. LCZ696 improves cardiac function via alleviating Drp1-mediated mitochondrial dysfunction in mice with doxorubicin-induced dilated cardiomyopathy. J Mol Cell Cardiol. 2017;108:138–148.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.